Product Wiki · Recalls · EU Safety Gate (RAPEX)

Hair Wax Gumgum — recall SR/03403/25

EU Safety Gate (RAPEX) · Germany · 2025-10-03 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/03403/25
Date of alert
2025-10-03
Country / jurisdiction
Germany
Risk level
Serious risk
Risk type
Chemical
Brand
Nishman
Product category
Cosmetics
Product type
Hair wax
Barcode (EAN/GTIN)
8682035088455
Reported risk: Das Produkt enthält Dibutylphthalat (DBP) (Messwert bis zu 0,00083 Gewichtsprozent). Dieses Phthalat kann die Gesundheit schädigen und mögliche Schäden am Fortpflanzungssystem oder am ungeborenen Kind verursachen. Das Produkt entspricht nicht der Verordnung über kosmetische Mittel.
Action taken by the authority
Type of economic operator taking notified measure
Distributor
Category of measure
Withdrawal of the product from the market
Date of entry into force
28/08/2025
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Hair Wax Gumgum

Risk Description (original English): The product contains dibutyl phthalate (DBP) (measured value up to 0.00083 % by weight). This phthalate may harm the health, causing possible damage to the reproductive system or the unborn child.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10096024

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.